Clinical Trial Update: A Study of PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia A [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating PEGylated recombinant Factor VIII (BAX855) in previously untreated young children with severe Hemophilia A has completed and posted r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• BAX855 (pegylated recombinant factor VIII)

Snippet

Sponsor: Baxalta now part of Shire | Conditions: Hemophilia A | Phase 3 | Status: COMPLETED | Results posted: 2025-07-28